Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

Arkin Capital has announced the closing of Arkin Bio Ventures III, a $100m fund designed to invest in pre-clinical and early clinical-stage biotechnology companies whose work has the potential to address high unmet medical need. Arkin Bio Ventures III builds on two previous funds, Arkin Bio Ventures I in 2016 and Arkin Bio Ventures II […] The post Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech appeared first on Pharmafile.

Continue reading →